State Street Corp ownership in NVAX / Novavax, Inc.

Novavax, Inc.

CH ˙ SWX ˙ US6700024010

Security	CH:NVAX / Novavax, Inc.
Institution	State Street Corp
Latest Disclosed Ownership	9,523,646 shares
Ownership	5.90%

2026-02-09 - State Street Corp has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 9,523,646 shares of Novavax, Inc. (CH:NVAX). This represents 5.9 percent ownership of the company. In their previous filing dated 2024-07-10 , State Street Corp had reported owning 6,066,179 shares, indicating an increase of 57.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2026-02-09	2026-02-09	13G	6,066,179	9,523,646	57.00	5.90	36.57
2024-07-10	2024-07-10	13G/A	16,775,875	6,066,179	-63.84	4.32	-69.41
2024-01-25	2024-01-25	13G/A	10,452,512	16,775,875	60.50	14.12	16.60
2023-05-10	2023-05-10	13G/A	6,076,518	10,452,512	72.01	12.11	69.37
2023-02-02	2023-02-02	13G/A	12,110,908	6,076,518	-49.83	7.15	85.23
2018-02-13	2018-02-13	13G/A	19,971,040	12,110,908	-39.36	3.86	-47.55
2017-02-08	2017-02-08	13G		19,971,040		7.36

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-15	2026-03-31	13F	NOVAVAX	COM NEW	670002401	8,970,518	-553,128	-5.81	73,020	14.10	0.0025
2026-02-13	2025-12-31	13F	NOVAVAX	COM NEW	670002401	9,523,646	2,326,927	32.33	63,999	2.57	0.0021
2025-11-14	2025-09-30	13F	NOVAVAX	COM NEW	670002401	7,196,719	372,468	5.46	62,396	45.13	0.0022
2025-08-14	2025-06-30	13F	NOVAVAX	COM NEW	670002401	6,824,251	-214,907	-3.05	42,993	-4.72	0.0016
2025-05-15	2025-03-31	13F	NOVAVAX	COM NEW	670002401	7,039,158	-662,208	-8.60	45,121	-27.13	0.0019
2025-02-14	2024-12-31	13F	NOVAVAX	COM NEW	670002401	7,701,366	13,415	0.17	61,919	-36.23	0.0024
2024-11-14	2024-09-30	13F	NOVAVAX	COM NEW	670002401	7,687,951	1,621,772	26.73	97,099	26.43	0.0040
2024-08-14	2024-06-30	13F	NOVAVAX	COM NEW	670002401	6,066,179	-10,840,391	-64.12	76,798	-4.97	0.0034
2024-05-15	2024-03-31	13F	NOVAVAX	COM NEW	670002401	16,906,570	130,695	0.78	80,813	0.36	0.0036
2024-02-14	2023-12-31	13F	NOVAVAX	COM NEW	670002401	16,775,875	6,601,258	64.88	80,524	9.31	0.0039
2023-11-14	2023-09-30	13F	NOVAVAX	COM NEW	670002401	10,174,617	-1,504,811	-12.88	73,664	-15.11	0.0041
2023-08-14	2023-06-30	13F	NOVAVAX	COM NEW	670002401	11,679,428	576,803	5.20	86,778	12.79	0.0046
2023-05-15	2023-03-31	13F	NOVAVAX	COM NEW	670002401	11,102,625	5,026,107	82.71	76,941	23.17	0.0043
2023-05-15	2022-12-31	13F/A-99	NOVAVAX	COM NEW	670002401	6,076,518	2,421,090	66.23	62,467	-6.11	0.0037
2023-05-15	2022-12-31	13F	NOVAVAX	COM NEW	670002401	6,076,518	2,421,090		62,467		0.0037
2022-11-15	2022-09-30	13F	NOVAVAX	COM NEW	670002401	3,655,428	688,564	23.21	66,529	-56.40	0.0042
2022-08-15	2022-06-30	13F	NOVAVAX	COM NEW	670002401	2,966,864	471,322	18.89	152,586	-16.98	0.0091
2022-05-16	2022-03-31	13F	NOVAVAX	COM NEW	670002401	2,495,542	596,322	31.40	183,797	-32.36	0.0091
2022-02-14	2021-12-31	13F	NOVAVAX	COM NEW	670002401	1,899,220	152,593	8.74	271,721	-24.96	0.0129
2021-11-15	2021-09-30	13F	NOVAVAX	COM NEW	670002401	1,746,627	53,237	3.14	362,093	0.71	0.0191
2021-08-16	2021-06-30	13F	NOVAVAX	COM NEW	670002401	1,693,390	251,437	17.44	359,524	37.52	0.0189
2021-07-09	2021-03-31	13F/A-1	NOVAVAX	COM NEW	670002401	1,441,953	-284,229	-16.47	261,440	35.82	0.0150
2021-05-17	2021-03-31	13F	NOVAVAX	COM NEW	670002401	1,441,953	-284,229		261,440		0.0150
2021-02-16	2020-12-31	13F	NOVAVAX	COM NEW	670002401	1,726,182	17,323	1.01	192,487	3.96	0.0118
2020-11-10	2020-09-30	13F	NOVAVAX	COM NEW	670002401	1,708,859	-604,488	-26.13	185,155	-3.97	0.0126
2020-08-14	2020-06-30	13F	NOVAVAX	COM NEW	670002401	2,313,347	1,733,715	299.11	192,817	2,349.71	0.0140
2020-06-19	2020-03-31	13F/A-1	NOVAVAX	COM NEW	670002401	579,632	152,556	35.72	7,871	363.00	0.0007
2020-05-11	2020-03-31	13F	NOVAVAX	COM NEW	670002401	579,632	152,556		7,871		691.2323
2020-02-06	2019-12-31	13F	NOVAVAX	COM NEW	670002401	427,076	2,887	0.68	1,700	-20.15	0.0001
2019-11-14	2019-09-30	13F	NOVAVAX	COM NEW	670002401	424,189	14,066	3.43	2,129	-11.40	0.0002
2019-08-14	2019-06-30	13F	NOVAVAX	COM NEW	670002401	410,123	-7,393,327	-94.74	2,403	-44.10	0.0002
2019-05-15	2019-03-31	13F	NOVAVAX	COM	670002104	7,803,450	-6,916,144	-46.99	4,299	-84.13	0.0003
2019-02-12	2018-12-31	13F	NOVAVAX	COM	670002104	14,719,594	-2,658,231	-15.30	27,084	-17.11	0.0025
2018-11-09	2018-09-30	13F	NOVAVAX	Common equity shares	670002104	17,377,825	-5,929,871	-25.44	32,674	4.62	0.0025
2018-08-14	2018-06-30	13F	NOVAVAX	Common equity shares	670002104	23,307,696	-1,923,889	-7.62	31,230	-41.06	0.0026
2018-05-15	2018-03-31	13F	NOVAVAX	Common equity shares	670002104	25,231,585	13,121,677	108.35	52,988	252.92	0.0045
2018-02-14	2017-12-31	13F	NOVAVAX	Common equity shares	670002104	12,109,908	6,827,338	129.24	15,014	149.40	0.0012
2017-11-14	2017-09-30	13F	NOVAVAX	Common equity shares	670002104	5,282,570	-5,567	-0.11	6,020	-1.05	0.0005
2017-08-14	2017-06-30	13F	NOVAVAX	Common equity shares	670002104	5,288,137	-7,814,739	-59.64	6,084	-63.73	0.0005
2017-05-15	2017-03-31	13F	NOVAVAX	Common equity shares	670002104	13,102,876	-6,868,164	-34.39	16,772	-33.35	0.0015
2017-02-09	2016-12-31	13F	NOVAVAX	Common equity shares	670002104	19,971,040	9,947,481	99.24	25,163	20.69	0.0024
2017-01-13	2016-09-30	13F/A-1	NOVAVAX	Common equity shares	670002104	10,023,559	1,008,916	11.19	20,849	-68.19	0.0021
2016-11-14	2016-09-30	13F	NOVAVAX	Common equity shares	670002104	10,023,559			20,849
2016-08-12	2016-06-30	13F	NOVAVAX	Common equity shares	670002104	9,014,643	-3,306,197	-26.83	65,542	3.09	0.0070
2016-05-20	2016-03-31	13F/A-1	NOVAVAX	Common equity shares	670002104	12,320,840	3,527,714	40.12	63,579	-13.82	0.0069
2016-05-12	2016-03-31	13F	NOVAVAX	Common equity shares	670002104	12,320,840			63,579
2016-02-16	2015-12-31	13F	NOVAVAX	Common equity shares	670002104	8,793,126	1,620,264	22.59	73,772	45.46	0.0081
2015-11-16	2015-09-30	13F	NOVAVAX	Common equity shares	670002104	7,172,862	42,055	0.59	50,715	-36.16	0.0059
2015-08-13	2015-06-30	13F	NOVAVAX	Common equity shares	670002104	7,130,807	940,919	15.20	79,436	55.17	0.0085
2015-05-15	2015-03-31	13F	NOVAVAX	Common equity shares	670002104	6,189,888	-427,132	-6.46	51,194	30.46	0.0053
2015-02-11	2014-12-31	13F	NOVAVAX	Common equity shares	670002104	6,617,020	-335,503	-4.83	39,240	35.37	0.0039
2014-11-12	2014-09-30	13F/A-1	NOVAVAX	Common equity shares	670002104	6,952,523	785,574	12.74	28,988	1.73	0.0031
2014-11-10	2014-09-30	13F	NOVAVAX	Common equity shares	670002104	6,952,523			28,988
2014-08-12	2014-06-30	13F	NOVAVAX	Common equity shares	670002104	6,166,949	-224,938	-3.52	28,494	-1.59	0.0031
2014-05-15	2014-03-31	13F/A-1	NOVAVAX	Common equity shares	670002104	6,391,887	-399,594	-5.88	28,955	-16.74	0.0033
2014-05-13	2014-03-31	13F	NOVAVAX	Common equity shares	670002104	6,395,804			28,973
2014-02-06	2013-12-31	13F/A-1	NOVAVAX	Common equity shares	670002104	6,791,481	4,661,500	218.85	34,776	416.27	0.0039
2014-02-06	2013-12-31	13F	NOVAVAX	Common equity shares	670002104	1,880,633			3,552
2013-11-12	2013-09-30	13F	NOVAVAX	Common Stock	670002104	2,129,981	100,591	4.96	6,736	61.92	0.0008
2013-08-08	2013-06-30	13F	NOVAVAX	Common Stock	670002104	2,029,390	2,029,390		4,160		0.0005

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.